Continuing Medical Education
Imedex, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
This activity has been approved for AMA PRA Category 1 CreditTM.
Who Should Attend
This educational activity is specifically designed for oncologists, hematologists, and other healthcare professionals, including nurses and pharmacists, interested and/or involved in the care of patients with cancer.
Objectives
After successful completion of this course, participants should be able to:
- Identify recent advances in therapy for breast cancer, especially for metastatic ERBB2 (formerly HER2) positive
tumors, and optimize chemotherapeutic regimens
- Identify emerging trends in adjuvant therapy for colorectal cancer (CRC), and optimize management of upper GI tract adenocarcinoma
- Describe recent advances in hematologic malignancies, especially frontline therapy for newly diagnosed myeloma, as well as genetic and molecular factors in planning therapy for
acute leukemia
- Optimize sequencing and combinations of current and emerging therapies in renal cell carcinoma (RCC) and castrate-resistant prostate cancer
- Identify emerging adjuvant and maintenance therapies for non-small-cell lung cancer (NSCLC) and discuss options after postmaintenance relapse
- Evaluate therapeutic advances and clinical updates in orphan cancers such as T-cell lymphoma, melanoma, small-cell lung, thyroid, and biliary tract cancers
Breast Cancer
Optimal chemotherapy regimens for breast cancer
Management of metastatic HER-2 positive breast cancer
Gastrointestinal Cancers
Adjuvant therapy of CRC: Has anything changed?
Emerging trends in the management of upper gastrointestinal tract adenocarcinoma
Orphan Cancers
Clinical updates in T-cell lymphoma
Advances in the management of thyroid cancers
Melanoma: Improving clinical outcomes through advances in immunotherapeutics and targeted therapy
Biliary tract cancer: Has the standard of care changed?
Updates in gynecologic oncology
Hematologic Malignancies
Frontline therapy for newly diagnosed myeloma
The remaining challenges in chronic leukemia
Acute leukemia/myelodysplastic syndrome (MDS): Clinical genomic and molecular factors in therapeutic planning
Genitourinary Oncology
Optimal sequencing and combinations of current and emerging therapies in RCC
Current and emerging concepts in the management of patients with castrate resistant prostate cancer
Lung Cancer
Adjuvant therapy for NSCLC: Impact of recent clinical trial updates on community practice
Maintenance therapy for advanced NSCLC: When, what, why and what’s left after post-maintenance relapse
Novel targets and agents in development for NSCLC
Meet the Expert Concurrent Sessions
Managing myeloma in first and subsequent relapses
Managing follicular lymphoma: Mundane or maddening?
Head and neck cancer
Small cell lung cancer
NEW THIS YEAR
Oncology Symptom Management Concurrent Sessions
Non-estrogenic management of hot flashes
What to tell your patients about vitamins and complementary medications
Prevention/treatment of chemotherapy-induced neuropathy
Lunch Symposium on Challenges in the Oncology Healthcare Community
Reimbursement issues
U.S. healthcare: Policy and politics
Registration Fees
$175 Physicians
$100 Nurses, students and fellows
–$50 Group discount
Cannot be combined with any other discounts
Registration Procedures
To Register: You may register online by February 11, 2010 at www.nocrannualmeeting.com, by calling Imedex at +1 (678) 242 0906, or by returning the registration form in this program by mail or fax. If you mail the form, please keep a copy for your records. Registration confirmations will be issued before the meeting.
To qualify for special registration fees, registration and full payment must be received by Imedex by the date specified.
Group Discounts: Each one of multiple registrants from the same institute or practice will receive a $50 discount off the published registration fees, provided all registration forms and payments are received together. Only one discount will apply per person.
The Registration and Information Desk onsite will be staffed: Friday, February 19, 2010 7:00 am - 4:30 pm Saturday, February 20, 2010 7:00 am - 4:15 pm
Payment: To pre-register, registration and payment must be received no later than February 11, 2010. Please register onsite after this date. Contact Imedex at +1 (678) 242 0906, or visit our website at www.nocrannualmeeting.com to ensure the course is being held as scheduled, and to confirm that the meeting is not full. Registration fees must be remitted by credit card or check. Checks should be payable to Imedex. Attendee is not registered until full payment is received.
Registration Fee Inclusions: Registration fees include admittance to all scientific sessions, conference materials, processing of certificates of attendance or continuing medical education, and all event functions as specified in the agenda.
Cancellation: For registration fees to be refunded, written notice of cancellation must be received at meetings@imedex.com no later than February 11, 2010. The amount of registration fees remitted, minus a $50 administrative charge, will be refunded after the conference. Substitutions are accepted with written notification. No refunds will be made if notice is received after February 11, 2010.
Imedex does not accept responsibility for covering travel, accommodation or any other costs incurred by registrants in the rare event that this meeting should be canceled for any reason. Every effort will be made to give reasonable notice in the event of cancellation. The event agenda is subject to change without notice.
Caesars Palace: Located on the Las Vegas Strip, Caesars Palace is a Las Vegas landmark. With its towering row of fountains leading to its entrance, this hotel revolutionized the Strip when it opened in 1966. Now it’s almost a city unto itself. This Roman themed hotel has all the amenities one has come to expect from a Las Vegas venue. All meeting functions will take place in the Palace Tower where a limited number of sleeping rooms have been reserved.
Caesars Palace
3570 Las Vegas Boulevard South
|
Las Vegas, NV 89109
Tel.: +1 (866) 227-5938
www.caesarspalace.com
For the convenience of attendees, a limited number of rooms have been reserved in the Palace Tower until January 19, 2010 at a discounted rate of $209 per night single or double occupancy, plus tax, currently at 12%. There is an additional charge of $30 per person, per night, for more than two people in a room, with a maximum of 4 people per guestroom. This rate is not guaranteed outside the conference dates or after Tuesday, January 19, 2010.
To reserve your room please contact the Caesars Palace reservations department at +1 (866) 227-5924. The discounted rate is not available online. To receive the group rate, callers must identify themselves as being with the 16th Annual NOCR Meeting group. Reservation requests received after Tuesday, January 19, 2010 may not be guaranteed the group rate.
Caesars Palace Policies
Each guestroom must have at least one registered guest of 21 years or age or older
All reservations must be guaranteed with a deposit equal to the first night’s guestroom and tax charge. Guests can cancel their hotel room up to 72 hours before their scheduled arrival date without penalty. If cancelation is made less than 72 hours before the scheduled arrival date guest will be charged for 1 night plus tax.
Check-in time is 4 pm. Check-out time is 11 am. Any departures after 11 am are subject to the full day charge
DEAR COLLEAGUE
We are pleased to welcome you back to Las Vegas, Nevada for the 16th Annual NOCR Meeting - the premier annual event for community oncologists to update their clinical knowledge.
This annual update features clinical case discussions, debates, Meet the Expert sessions, and panel discussions for exchanging the latest information on the diagnosis and management of solid tumors and hematologic malignancies. Attendees will have the opportunity to interact with our internationally renowned faculty through an audience response system.
We are excited to expand this year’s Annual NOCR Meeting to include all members of your practice team. The agenda includes new concurrent sessions on oncology symptom management, and a symposium on challenges in the oncology healthcare community, including reimbursement issues and U.S. healthcare policies.
We hope you will join us for what is sure to be an outstanding educational experience!
ORGANIZER
Imedex
4325 Alexander Drive
Alpharetta, GA 30022-3740 USA
Tel.: +1 (770) 751 7332
Fax: +1 (770) 751 7334
Email: meetings@imedex.com
Web: www.imedex.com
Imedex is a brand and assumed name used by Imedex, LLC (hereby referred to as Imedex). Imedex is solely responsible for this agenda’s content. Although Imedex attempts to ensure that the information in our program is accurate and timely, matters and opinions discussed and/or presented with respect to clinical matters are those of the discussion participants only, and not necessarily those of Imedex. Moreover, although Imedex attempts to identify and integrate the most qualified medical professionals in our program, TO THE FULLEST EXTENT PERMITTED BY LAW, IMEDEX EXPRESSLY DISCLAIM ALL WARRANTIES, EITHER EXPRESS OR IMPLIED, STATUTORY OR OTHERWISE, INCLUDING BUT NOT LIMITED TO THE IMPLIED WARRANTIES OF MERCHANTABILITY, NON-INFRINGEMENT OF THIRD PARTIES’ RIGHTS, AND FITNESS FOR A PARTICULAR PURPOSE, WITH RESPECT TO THE CONTENT PRESENTED. IMEDEX FURTHER MAKES NO REPRESENTATIONS OR WARRANTIES ABOUT THE ACCURACY, RELIABILITY, COMPLETENESS OR TIMELINESS OF THE CONTENT OR ANY MATERIAL PRESENTED.
In addition, the material presented and related discussions are not intended to be medical advice, and the presentation or discussion of such material is not intended to create and does not establish a physician-patient relationship. Medical advice of any nature should be sought from an individual’s own physician.
Neither Imedex nor any of its subsidiaries or affiliates is affiliated with or formally endorsed by a medical society.
©2009 Imedex®, LLC. All rights reserved.
Reproduction in whole or part is prohibited without prior written consent from Imedex and contributing faculty.
The following companies have provided an educational grant in support of this conference:
GOLD
Genentech BioOncology
SILVER
BRONZE
Several options are available to companies interested in supporting this Congress. For more information, please contact Imedex at +1(770) 751 7332, or by email at cme@imedex.com.
Opportunities are available to companies interested in exhibiting at this conference. For more information, please contact Cori Gunter at +1(678) 242 0712 or by email at c.gunter@imedex.com.
